← FDA Drug Approvals (Drugs@FDA)

PATANASE

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2008-04-15

Drug application

FDA Application #

NDA021861

Application type

New Drug Application

Brand name

PATANASE

Generic name

Olopatadine Hydrochloride

Active ingredients

OLOPATADINE HYDROCHLORIDE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2008-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown